JP2023522066A5 - - Google Patents

Info

Publication number
JP2023522066A5
JP2023522066A5 JP2022563013A JP2022563013A JP2023522066A5 JP 2023522066 A5 JP2023522066 A5 JP 2023522066A5 JP 2022563013 A JP2022563013 A JP 2022563013A JP 2022563013 A JP2022563013 A JP 2022563013A JP 2023522066 A5 JP2023522066 A5 JP 2023522066A5
Authority
JP
Japan
Prior art keywords
stroke
individual
lvo
amount
biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022563013A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522066A (ja
JP7711092B2 (ja
Filing date
Publication date
Priority claimed from GB2005632.1A external-priority patent/GB2594094A/en
Application filed filed Critical
Publication of JP2023522066A publication Critical patent/JP2023522066A/ja
Publication of JP2023522066A5 publication Critical patent/JP2023522066A5/ja
Application granted granted Critical
Publication of JP7711092B2 publication Critical patent/JP7711092B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022563013A 2020-04-17 2020-12-22 大血管閉塞により引き起こされる卒中についてのバイオマーカーとしてのｄ－ダイマー、グリア線維酸性タンパク質（ｇｆａｐ）、オステオプロテジェリン（ｏｐｇ）及びオステオポンチン（ｏｐｎ） Active JP7711092B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2005632.1 2020-04-17
GB2005632.1A GB2594094A (en) 2020-04-17 2020-04-17 Method for diagnosing stroke caused by large vessel occlusion
PCT/GB2020/053340 WO2021209732A1 (en) 2020-04-17 2020-12-22 D-dimer, glial fibrillary acidic protein (gfap), osteoprotegerin (opg) and osteopontin (opn) as biomarkers for stroke caused by large vessel occlusion

Publications (3)

Publication Number Publication Date
JP2023522066A JP2023522066A (ja) 2023-05-26
JP2023522066A5 true JP2023522066A5 (enExample) 2024-01-04
JP7711092B2 JP7711092B2 (ja) 2025-07-22

Family

ID=70860060

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563013A Active JP7711092B2 (ja) 2020-04-17 2020-12-22 大血管閉塞により引き起こされる卒中についてのバイオマーカーとしてのｄ－ダイマー、グリア線維酸性タンパク質（ｇｆａｐ）、オステオプロテジェリン（ｏｐｇ）及びオステオポンチン（ｏｐｎ）

Country Status (6)

Country Link
US (2) US11726100B2 (enExample)
EP (1) EP4136458A1 (enExample)
JP (1) JP7711092B2 (enExample)
KR (1) KR20230004594A (enExample)
GB (3) GB2594094A (enExample)
WO (1) WO2021209732A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121955401A (zh) * 2019-05-16 2026-05-01 瓦尔德西布伦大学医院基金会研究所 对于再灌注疗法选择患者的试剂盒及其制备和应用
GB2594094A (en) * 2020-04-17 2021-10-20 Pockit Diagnostics Ltd Method for diagnosing stroke caused by large vessel occlusion
JP2024532033A (ja) * 2021-04-15 2024-09-05 フンダチオ ホスピタル ウニベルシタリ ヴァルデブロン‐インスティテュート デ レセルカ 脳主幹動脈閉塞の診断のためのマーカー
KR20250004423A (ko) * 2023-06-29 2025-01-08 프리시젼바이오 주식회사 허혈성 뇌졸증 진단용 분석장치

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637459A (en) 1990-06-11 1997-06-10 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chimeric selex
US5683867A (en) 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
US5707796A (en) 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
US6011020A (en) 1990-06-11 2000-01-04 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand complexes
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
KR970002255B1 (ko) 1990-06-11 1997-02-26 넥스스타 파아마슈티컬드, 인크. 핵산 리간드
US5567588A (en) 1990-06-11 1996-10-22 University Research Corporation Systematic evolution of ligands by exponential enrichment: Solution SELEX
US5496938A (en) 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
AU2785999A (en) * 1998-02-24 1999-09-06 Jack Edward Juni Use of succinate as a diagnostic tool
US7392140B2 (en) 2003-09-23 2008-06-24 Prediction Sciences, Llc Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
CA2804802C (en) * 2010-07-15 2023-03-07 The Regents Of The University Of California Biomarkers for diagnosis of stroke and its causes
WO2012021407A2 (en) * 2010-08-13 2012-02-16 Morehouse School Of Medicine Biomarkers for stroke
GB201309928D0 (en) * 2013-06-04 2013-07-17 Randox Lab Ltd Method
EP3029466A1 (en) * 2014-12-03 2016-06-08 Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca Methods for differentiating ischemic stroke from hemorrhagic stroke
US11774457B2 (en) * 2018-07-09 2023-10-03 Wright State University Identification and analysis of protein biomarkers
CN121955401A (zh) 2019-05-16 2026-05-01 瓦尔德西布伦大学医院基金会研究所 对于再灌注疗法选择患者的试剂盒及其制备和应用
GB2594094A (en) 2020-04-17 2021-10-20 Pockit Diagnostics Ltd Method for diagnosing stroke caused by large vessel occlusion

Similar Documents

Publication Publication Date Title
Fan et al. Diagnosing sepsis–The role of laboratory medicine
US12085565B2 (en) SNTF is a blood biomarker for the diagnosis and prognosis of sports-related concussion
EP2796878A1 (en) New biomarkers for diagnosis, prediction and/or prognosis of sepsis and uses thereof
GB2600844A (en) D-dimer, glial fibrillary acidic protein (GFAP) osteoprotegerin (OPG) and osteopontin (OPN) as biomarkers for stroke caused by large vessel occlusion
JPWO2022071601A5 (enExample)
CN105588944B (zh) 检测agp1、serpina3和cdh1含量的系统在筛查活动性结核病患者中的应用
US20130210667A1 (en) Biomarkers for Predicting Kidney and Glomerular Pathologies
Bustamante et al. Sepsis biomarkers reprofiling to predict stroke-associated infections
CN110702917A (zh) 血清淀粉样蛋白p在制备抑郁症诊断治疗相关产品的用途
EP3864407A1 (en) Biomarker of chronic kidney disease in liver transplant recipients
TWI655433B (zh) 川崎氏症之診斷與治療
KR102328932B1 (ko) 신장이식 후 항체 매개성 거부반응의 진단 또는 예측을 위한 소변 엑소좀 바이오마커
JP2021523375A5 (enExample)
CN106461674A (zh) 一种用于诊断结核性脑膜炎的方法
CN110988351B (zh) 血管细胞黏附分子在制备抑郁症诊断治疗相关产品的用途
JP6252949B2 (ja) 統合失調症マーカーセット及びその利用
JP6934013B2 (ja) 糖尿病性腎症の早期病態の特異的な診断を可能とする検査方法
JP7497851B2 (ja) アルツハイマー病診断のためのアッセイ
EP3682236A1 (en) Proadrenomedullin as indicator for renal replacement therapy in critically ill patients
JP2022550825A (ja) 尿サンプル中において結核の診断を行なうための方法
US8394639B2 (en) Biomarkers for renal disease
WO2007148720A1 (ja) ネフローゼ症候群の疾患関連たんぱく質およびその使用
CN113215247A (zh) 一种自身免疫性甲状腺疾病预测及预后判断试剂盒及应用
WO2025167800A1 (en) Blood proteomic markers for stroke and methods thereof
US20260043813A1 (en) Chronic kidney disease detection